August 14, 2019 by Steven Robins
OTC medicines, prescription drug prices
August 12, 2019, Opinion
Now is the time for Food and Drug Administration reforms designed to dramatically increase the number of prescription-to-O-T-C switches in the U.S. At a time when both political parties are pushing for transparency and pricing reform, the opportunity to align multiple agendas that benefit consumers, retail pharmacies and the health care system overall is too
January 21, 2019 by Jeffrey Woldt
Affordable Care Act, NPC, prescription drug prices
January 21, 2019, Opinion
Everyone recognizes that the high cost of health care in the U.S. is a chronic problem, the fallout from which is hurting patients, constraining providers and preventing the nation from marshalling adequate resources to address other essential needs. As noted in this space earlier this month, the Affordable Care Act, the legislation that governs the
June 4, 2018 by Jeffrey Woldt
prescription drug prices, President Donald Trump
Issue 06-04-2018, Opinion
President Trump has unveiled the administration’s much anticipated plan to reduce pharmaceutical prices. Speaking in the White House Rose Garden last month, the president touted what he characterized as “the most sweeping action in history to lower the prices of prescription drugs for the American people.” Long on rhetoric and short on specifics, the initiative
February 12, 2018 by Greg Jacobson and Chain Drug Review
Alex Azar, Eli Lilly, Food and Drug Administration, HHS secretary, prescription drug prices, President Donald Trump, Secretary of Health and Human Services, State of the Union, Trump's State of the Union address
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — In his first State of the Union speech, President Donald Trump renewed his pledge to reduce prescription drug prices, days after a former big pharma executive was sworn in as Secretary of Health and Human Services. Trump had stunned the pharmaceutical industry during his 2016 campaign by declaring that drug manufacturers were “getting
March 15, 2017 by Chain Drug Review
CVS Caremark, CVS Caremark drug trend, CVS Health, prescription drug prices, Troyen Brennan
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health said it was able to counteract rising prescription drug prices for its pharmacy benefit management clients in 2016, achieving their lowest drug trend in the past four years. CVS said Wednesday that CVS Caremark clients saw their prescription drug trend fall to an average of 3.2% last year versus 5%
March 1, 2017 by CDR Blog and Chain Drug Review
Advisor Access, CVS Health, CVS Pharmacy, Dave Denton, Maintenance Choice 3.0, prescription drug prices, repeal of the Affordable Care Act, Target's pharmacy business
CDR Blog
CVS Health’s pharmacy care assets position the company well for growth, even in an evolving health care arena set for further change under a new presidential administration, executive VP and CFO Dave Denton said. In an interview posted this week on investment intelligence website Advisor Access, Denton outlined CVS’ strengths — namely, its integrated retail
January 12, 2017 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Donald Trump, drug industry, drug pricing, National Community Pharmacists Association, NCPA, PBMs, pharmaceutical industry, pharmacy benefit managers, prescription drug prices
CDR Blog
Donald Trump briefly touched on the pharmaceutical industry in his first major press conference since being elected president. In the news conference yesterday at Trump Tower in Manhattan, Trump talked about drug companies relocating overseas and referred to the rising cost of pharmaceuticals. “We’ve got to get our drug industry back,” Trump said after discussing
January 12, 2017 by Chain Drug Review
Andrew Cuomo, B. Douglas Hoey, costs of prescription drugs, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Pharmaceutical Care Management Association v. Gerhart, prescription drug prices, video
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
(*Note: Go to 42:05 of video for Cuomo’s discussion of prescription drug costs.) ALBANY, N.Y. — New York Gov. Andrew Cuomo unveiled a three-pronged plan to check soaring prescription drug prices, which he called a “tremendous problem” for the state and its residents. In his 2017 State of the State address on Wednesday, Cuomo proposed